PF-06446846

inhibits translation of PCSK9 ;structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 01/01/2022 - "The hydrogel is in situ constructed in tumor site by utilizing oxidized sodium alginate-modified tumor cell membrane vesicle (O-TMV) as a gelator, where axitinib is encapsulated in the lipid bilayer of O-TMV while 4-1BB antibody and proprotein convertase subtilisin/kexin type 9 inhibitor PF-06446846 nanoparticles are present in the cavities of hydrogel. "

1.	Hydrogels
2.	Lipid Bilayers (Lipid Bilayer)
3.	Alginates
4.	Axitinib (AG 013736)
5.	Proprotein Convertase 9